Moolec Science SA (NASDAQ:MLEC) Sees Large Increase in Short Interest

Posted by Doug Wharley on May 14th, 2026

Moolec Science SA (NASDAQ:MLEC – Get Free Report) saw a significant increase in short interest in April. As of April 30th, there was short interest totaling 114,402 shares, an increase of 759.0% from the April 15th total of 13,318 shares. Approximately 19.7% of the shares of the stock are short sold. Based on an average trading volume of 325,650 shares, the short-interest ratio is currently 0.4 days.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered Moolec Science from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th.

View Our Latest Report on Moolec Science

Hedge Funds Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new stake in shares of Moolec Science SA (NASDAQ:MLEC – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent reporting period. Institutional investors own 0.07% of the company’s stock.

Moolec Science Stock Performance

NASDAQ MLEC opened at $8.34 on Thursday. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $157.05. The stock has a 50 day simple moving average of $8.45 and a two-hundred day simple moving average of $7.70. The stock has a market cap of $6.09 million, a P/E ratio of -0.25 and a beta of 0.38.

Moolec Science (NASDAQ:MLEC – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported $47.49 EPS for the quarter. The company had revenue of $2.62 million during the quarter.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.